David Suhy is the founder of Earli. Earli has raised $104M in total funding. Latest round: Series A. Based in San Francisco Bay Area, United States.
David Suhy is the Chief Scientific Officer and Co-founder of Earli Inc., a biotechnology company focused on early cancer detection using a 'Synthetic Biopsy' platform. He co-founded the company in June 2018, bringing expertise from his involvement with the original research at Stanford University.
Full founder directory · Investor directory · Company funding database · Fundraising library